Stocks to Watch: Hims & Hers, Verde Clean Fuels

Dow Jones
02/07
 

By Kelly Cloonan

 

Hims & Hers Health is facing a crackdown from the Food and Drug Administration after the telehealth company said it would start offering copies of the Wegovy pill. The FDA said it would take "decisive steps" to restrict non-approved drugs that use GLP-1 active pharmaceutical ingredients. The FDA also said it will aim to combat advertising from drug companies, including Hims & Hers. Shares slid 14%, to $19.84, in after-hours trading.

Verde Clean Fuels suspended development of its Permian Basin project due to changes in natural-gas demand. The clean fuels company said the suspension is primarily a result of "changing market conditions driven by increasing demand for natural gas in the Permian Basin." It was working on the site as part of a joint development agreement with Diamondback Energy. The stock fell 13% to $1.17 in late trading.

 

Write to Kelly Cloonan at kelly.cloonan@wsj.com

 

(END) Dow Jones Newswires

February 06, 2026 18:40 ET (23:40 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10